
Quality of Life Tips
- Maintain a consistent daily routine to reduce stress and uncertainty
- Stay connected with family and friends for emotional support
- Join support groups to connect with others who understand your experience

Support and Connect with Others Living with Thyroid Eye Disease
Understanding TED
Thyroid Eye Disease (TED), also known as Graves’ Ophthalmopathy or Thyroid Orbitopathy, is an autoimmune inflammatory disorder affecting the orbital tissues around the eyes. It is primarily related to Graves’ disease, but TED is a distinct condition requiring different treatment.


Managing Body Image

Pack eye drops and medications

As of mid-2025, ongoing research continues to unveil promising new avenues, offering hope for improved outcomes for those living with this challenging autoimmune condition.
Connect with other TED patients in our private Facebook group. Share experiences, ask questions, and receive support from people who truly understand your journey. Private and secure environment • Moderated by neutral leadership • Patient-led discussions • Regular expert Q&A sessions
We explore some of the latest news about the disease and possible treatments.



Living with a rare disease like TED can seem overwhelming, but you're not alone. Joining our community means finding a place to listen, share and support with people who understand your day-to-day challenges.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
1-Thyroid Eye Disease (TED) is a well-recognized autoimmune disorder distinct from Graves’ disease. It affects up to 50% of patients with Graves’ disease, but around 10% of cases occur without it, including in hypothyroid or euthyroid individuals. Women between 30–50 years are at highest risk.
Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the management of Graves’ orbitopathy. Eur J Endocrinol. 2021;185(4):G43–G67. doi:10.1530/EJE-21-0479